Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Chronic Inflammatory Cardiomyopathy
NCT06158698Phase 3Recruiting
- Sponsor
- ASST Grande Ospedale Metropolitano Niguarda
- Start
- Nov 2023
- Primary completion
- May 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in inflammatory cardiomyopathy, sponsored by ASST Grande Ospedale Metropolitano Niguarda. Started Nov 2023; status: recruiting.
02
Drugs
colchicine
03
Conditions
inflammatory cardiomyopathy
Beyond the preview
Go deeper on NCT06158698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06158698.